Recommendation Report: The Use of the Inactivated SARS-CoV-2 BBIBP-CORV-CorV Sinopharm Vaccine

The UNITAG working group made the following recommendations:
a) BBIBP-CorV vaccine (Sinopharm) is recommended for use in Uganda for persons aged 18 years and above, since it meets the minimum use requirements of efficacy, safety, affordability and programmatic fit.
b) The Immunisation program should weigh the benefits of ease of use of the prefilled syringes against the additional cold-chain space requirements compared to the single dose vials before choosing the packaging option to go for.
c) Ministry of Health together with the Ministry of Finance and Economic Development should work together on issues related to vaccine cost and procurement. Preference is given to use of trusted channels such as UNICEF and African Union.